US · PI Dr. M. Okafor · activated
Patients
0
Active
0
Serious AEs
0
Open QA
0
Aged queries
0
Luna users
0
Studies & contracts
GAL-001: Adaptive Phase II in Refractory Melanoma
Phase II · study active · contract executed · 184000 USD
Patients (0)
No patients at this site.
Safety — 0 AEs, 0 serious
No serious adverse events.
QA findings (0 open)
No findings recorded.
Visits & payments
Nothing scheduled.
☾ Luna participants
No Luna participants here yet.